Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Deloitte
Chubb
Harvard Business School
Covington

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,816,396

« Back to Dashboard

Which drugs does patent 7,816,396 protect, and when does it expire?

Patent 7,816,396 protects CUVPOSA and is included in one NDA.

Summary for Patent: 7,816,396
Title:Method for increasing the bioavailability of glycopyrrolate
Abstract:The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.
Inventor(s): Roberts; Alan (Woodstock, GA), Venkataraman; Balaji (Alpharetta, GA)
Assignee: Shionogi Pharma, Inc. (Atlanta, GA)
Application Number:12/648,068
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,816,396
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,816,396
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 7,816,396

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Merz Pharms CUVPOSA glycopyrrolate SOLUTION;ORAL 022571-001 Jul 28, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Merck
Healthtrust
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.